Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
Launched by UNIVERSITY OF CONNECTICUT · Apr 26, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to help people lose weight using a digital program. One method allows participants to join a group online anytime they want (asynchronous), while the other method has participants meet weekly through video calls (synchronous). The trial aims to find out if both methods help people lose similar amounts of weight, which method encourages more participation, how connected participants feel with each other, and which method is more cost-effective.
To be eligible for this trial, participants must have a body mass index (BMI) between 27 and 45, have access to Wi-Fi or Bluetooth at home, and use Facebook regularly. They should also own a smartphone. Participants in the study will follow the digital weight loss program for a year and then, if they choose, lead the group for another year as part of a phase to maintain their weight loss. Throughout the study, participants will complete assessments at different times to track their progress. This trial is currently open for recruitment, and it offers a unique opportunity for individuals looking to lose weight in a supportive online environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI 27-45
- • has Bluetooth or wifi connectivity at home (for scale)
- • goes on Facebook at least 5 days per week over the past 2 weeks
- • has posted/replied at least once a week in the past 2 weeks (per self-report)
- • has a smart phone
- Exclusion Criteria:
- • Pregnant or lactating or plans to during study period
- • bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, or severe depression
- • had bariatric surgery or plans to during the study
- • currently taking meds affecting weight
- • lost ≥5% of weight in past 6 months
- • participating in another weight loss program or plans to during the study
- • chronic pain or medical condition that interferes with the ability to exercise
- • type 1 diabetes
- • unable to walk ¼ mile unaided without stopping
- • nicotine user
About University Of Connecticut
The University of Connecticut (UConn) is a leading academic institution committed to advancing health and science through innovative research and education. As a clinical trial sponsor, UConn leverages its extensive resources, including renowned faculty and state-of-the-art facilities, to conduct rigorous studies that contribute to medical knowledge and improve patient care. The university fosters a collaborative environment, engaging multidisciplinary teams to explore novel therapies and interventions across various health-related fields. UConn's dedication to ethical practices and compliance ensures the integrity and reliability of its clinical research, ultimately aiming to enhance health outcomes and address critical challenges in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Storrs, Connecticut, United States
Patients applied
Trial Officials
Sherry Pagoto, PhD
Principal Investigator
University of Connecticut
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported